Henry Schein, Inc. $HSIC Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 171.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 820,698 shares of the company’s stock after buying an additional 518,914 shares during the quarter. SG Americas Securities LLC’s holdings in Henry Schein were worth $62,028,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. CYBER HORNET ETFs LLC purchased a new stake in Henry Schein during the 2nd quarter worth $25,000. MUFG Securities EMEA plc acquired a new position in Henry Schein in the 2nd quarter worth $27,000. Sentry Investment Management LLC boosted its position in Henry Schein by 132.1% in the 3rd quarter. Sentry Investment Management LLC now owns 905 shares of the company’s stock valued at $59,000 after buying an additional 515 shares during the last quarter. Mather Group LLC. acquired a new stake in shares of Henry Schein during the third quarter valued at about $71,000. Finally, CX Institutional grew its stake in shares of Henry Schein by 75.6% during the third quarter. CX Institutional now owns 1,143 shares of the company’s stock valued at $76,000 after acquiring an additional 492 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Thomas C. Popeck sold 1,355 shares of the firm’s stock in a transaction dated Thursday, March 19th. The shares were sold at an average price of $72.79, for a total value of $98,630.45. Following the transaction, the chief executive officer owned 86,182 shares of the company’s stock, valued at $6,273,187.78. This trade represents a 1.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Kurt P. Kuehn sold 2,844 shares of Henry Schein stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $78.96, for a total value of $224,562.24. Following the completion of the transaction, the director owned 15,420 shares of the company’s stock, valued at approximately $1,217,563.20. The trade was a 15.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 105,911 shares of company stock valued at $8,574,982 over the last ninety days. Insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on HSIC. Leerink Partners reiterated a “market perform” rating on shares of Henry Schein in a research note on Monday, March 9th. Mizuho raised their price objective on Henry Schein from $81.00 to $88.00 and gave the company a “neutral” rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. lifted their price objective on Henry Schein from $78.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th. UBS Group upped their target price on Henry Schein from $79.00 to $87.00 and gave the company a “neutral” rating in a research report on Wednesday, February 25th. Finally, Robert W. Baird set a $100.00 target price on Henry Schein and gave the company an “outperform” rating in a research note on Monday, February 23rd. Six analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Hold” and an average target price of $85.58.

Henry Schein Stock Down 0.6%

HSIC stock opened at $74.02 on Wednesday. The firm has a market cap of $8.49 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 2.20 and a beta of 0.88. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $89.29. The firm has a fifty day moving average price of $77.65 and a two-hundred day moving average price of $73.13. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.38 and a quick ratio of 0.76.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.30 by $0.04. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The company had revenue of $3.44 billion for the quarter, compared to the consensus estimate of $3.34 billion. During the same period last year, the firm posted $1.19 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.